Bajaj Healthcare Ratios

Bajaj Healthcare Ltd Ratios

The Bajaj Healthcare Ltd Ratios page provides a complete fundamental analysis of Bajaj Healthcare Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Bajaj Healthcare Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Bajaj Healthcare Ltd (NSE: BAJAJHCARE, BSE: 539872) is currently trading at ₹312.95, with a market capitalization of ₹9.9B. As a major player in the Health technology sector and Pharmaceuticals: major industry, Bajaj Healthcare Ltd remains a key stock for fundamental analysis using Bajaj Healthcare Ltd Ratios.

Bajaj Healthcare Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Bajaj Healthcare Ltd P/E ratio currently stands at 51.20, making it one of the most tracked metrics in Bajaj Healthcare Ltd Ratios.

Historically, the Bajaj Healthcare Ltd P/E ratio has shown strong fluctuations:

• 2024: 51.20
• 2023: 0
• 2022: 19.55
• 2021: 13.16
• 2020: 7.83

The rising Bajaj Healthcare Ltd P/E ratio indicates increasing investor confidence and premium valuation.

Price to Book Ratio (P/B)

The Bajaj Healthcare Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 4.55.

Historical P/B trend:

• 2024: 4.55
• 2023: 2.90
• 2022: 2.29
• 2021: 2.86

Bajaj Healthcare Ltd is trading at a premium to its book value, indicating strong market confidence.

Price to Sales Ratio (P/S)

The Bajaj Healthcare Ltd P/S ratio currently stands at 3.73, an important part of Bajaj Healthcare Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 3.73
• 2023: 1.71
• 2022: 1.30
• 2021: 1.38

The rising Bajaj Healthcare Ltd P/S ratio indicates improved revenue valuation by investors.

Bajaj Healthcare Ltd Price to Cash Flow Ratio (P/CF)

The Bajaj Healthcare Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Bajaj Healthcare Ltd Price to Cash Flow Ratio:

• 2024: 0
• 2023: 15.91
• 2022: 0
• 2021: 0
• 2020: 18.37

The declining Bajaj Healthcare Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Bajaj Healthcare Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Bajaj Healthcare Ltd EV currently stands at ₹22.41B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 22.41B
• 2023: 11.37B
• 2022: 12.37B
• 2021: 11.94B

Bajaj Healthcare Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.

EV/EBITDA Ratio

The Bajaj Healthcare Ltd EV/EBITDA ratio is currently 26.85, a key metric in Bajaj Healthcare Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 26.85
• 2023: 33.23
• 2022: 10.91
• 2021: 9.66

Stable Bajaj Healthcare Ltd EV/EBITDA indicates balanced valuation.

Bajaj Healthcare Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Bajaj Healthcare Ltd D/E ratio is currently 0.48, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.48
• 2023: 1.20
• 2022: 1.13
• 2021: 0.78

Bajaj Healthcare Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Bajaj Healthcare Ltd ROE currently stands at 11.53%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 11.53
• 2023: -4.44
• 2022: 18.25
• 2021: 24.33

Bajaj Healthcare Ltd maintains stable profitability levels.

Bajaj Healthcare Ltd Ratios Analysis Summary

The Bajaj Healthcare Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Bajaj Healthcare Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Bajaj Healthcare Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.